Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

By activating a master epigenetic switch using CRISPR, naturally suppressed genes can be turned on, offering hope for Prader-Willi syndrome.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic ...